|
[1]
|
胡亚美, 江载芳, 申昆玲. 诸福棠实用儿科学[M]. 第8版. 北京: 人民卫生出版社, 2015: 1248-1249.
|
|
[2]
|
李立, 廖星, 赵静, 等. 中国小儿急性上呼吸道感染相关临床指南的解读[J]. 中国中药杂志, 2017, 42(8): 1510-1513.
|
|
[3]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
|
[4]
|
范雪, 徐明国. 川崎病发病机制及治疗研究进展[J]. 中国实用儿科杂志, 2021, 36(5): 340.
|
|
[5]
|
陈强, 訾慧芬, 侯毅, 等. 川崎病的诊治进展[J]. 中国中西医结合儿科学, 2020, 12(5): 387-388.
|
|
[6]
|
Onouchi, Y. (2017) The Genetics of Kawasaki Disease. International Journal of Rheumatic Diseases, 21, 26-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ding, Y., Li, G., Xiong, L., Yin, W., Liu, J., Liu, F., et al. (2015) Profiles of Responses of Immunological Factors to Different Subtypes of Kawasaki Disease. BMC Musculoskeletal Disorders, 16, Article No. 315. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
樊志丹, 俞海国, 胡坚, 等. 中国儿童血管炎诊断与治疗系列专家共识之四——川崎病[J]. 中国实用儿科杂志, 2023, 38(7): 485.
|
|
[9]
|
汪受传. 小儿急性上呼吸道病毒感染中医诊疗指南[J]. 南京中医药大学学报, 2011, 27(3): 204-208.
|
|
[10]
|
秦璨, 魏兵, 齐双辉. 川崎病血管损伤的中西医研究进展[J]. 实用中医内科杂志, 2020, 34(6): 44-45.
|
|
[11]
|
吴瑭. 温病条辨[M]. 北京: 人民卫生出版社, 2005: 16-19.
|
|
[12]
|
韩新民. 中医儿科学[M]. 第2版. 北京: 高等教育出版社, 2016.
|
|
[13]
|
马丽萍, 欧阳波, 谢方方, 等. 银翘散加减治疗急性上呼吸道感染疗效观察[J]. 中国医学文摘(耳鼻咽喉科学), 2022, 37(5): 104.
|
|
[14]
|
郭倩, 李金红, 李扬名. 银翘散联合丙种球蛋白和阿司匹林治疗川崎病的疗效及对患儿血清免疫功能和炎症因子的影响[J]. 河北中医, 2022, 44(4): 626.
|
|
[15]
|
牛明, 张斯琴, 张博, 等. 《网络药理学评价方法指南》解读[J]. 中草药, 2021, 52(14): 4119.
|
|
[16]
|
Rigante, D. (2020) Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection. Mediterranean Journal of Hematology and Infectious Diseases, 12, e2020039. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Domiciano, T.P., Wakita, D., Jones, H.D., Crother, T.R., Verri, W.A., Arditi, M., et al. (2017) Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis. Scientific Reports, 7, Article No. 41539. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
刘彩虹, 杨红辉, 卢俊娟. 山柰酚减轻慢性阻塞性肺疾病模型小鼠的炎症反应[J]. 中国病理生理杂志, 2021, 37(9): 1655.
|
|
[19]
|
Li, S., Yang, T., Lai, C., Huang, S., Liao, J., Wan, L., et al. (2014) Antiviral Activity of Aloe-Emodin against Influenza a Virus via Galectin-3 Up-Regulation. European Journal of Pharmacology, 738, 125-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
张宜. 基于NLRP3通路探讨芦荟大黄素保护血管内皮的作用机制[D]: [硕士学位论文]. 广州: 广州中医药大学, 2022.
|
|
[21]
|
Reece, M.D., Song, C., Hancock, S.C., Pereira Ribeiro, S., Kulpa, D.A. and Gavegnano, C. (2022) Repurposing BCL-2 and Jak 1/2 Inhibitors: Cure and Treatment of HIV-1 and Other Viral Infections. Frontiers in Immunology, 13, Article ID: 1033672. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Sabapathy, K. and Lane, D.P. (2019) Understanding P53 Functions through P53 Antibodies. Journal of Molecular Cell Biology, 11, 317-329. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Li, X., Bechara, R., Zhao, J., McGeachy, M.J. and Gaffen, S.L. (2019) IL-17 Receptor-Based Signaling and Implications for Disease. Nature Immunology, 20, 1594-1602. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
潘燕蝶, 潘小丹, 李洁, 等. 慢性阻塞性肺疾病继发肺部感染的炎性因子及TLR7/IL-23/IL-17信号通路作用[J]. 中华医院感染学杂志, 2020, 30(7): 997.
|
|
[25]
|
Nandi, A., Pal, P. and Basu, S. (2019) A Comparison of Serum IL6 and CRP Levels with Respect to Coronary Changes and Treatment Response in Kawasaki Disease Patients: A Prospective Study. Rheumatology International, 39, 1797-1801. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Xie, X., Shi, X. and Liu, M. (2017) The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-Analysis of Genetic Association Studies. Pediatric Cardiology, 39, 207-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
郭鑫, 刘琮, 王国兵, 等. 川崎病冠状动脉内皮细胞损伤的定量蛋白组学研究与生物信息学分析[J]. 中国当代儿科杂志, 2020, 22(7): 802.
|